Deyin Guo PhD, acted as WSV Vice President – Asia (2022-2024). He is a Professor of Medical Microbiology & Virology and dean at the School of Medicine, Sun Yat-sen University (since Sept. 2016). Dr. Guo obtained his Ph.D in Microbiology from the Faculty of Biosciences, Braunschweig University of Technology in Germany, and received his postdoctoral training at the Institute of Biotechnology, University of Helsinki, Finland. He has been a professor in microbiology/virology at Wuhan University since 2002. He served as the dean of the School of Basic Medical Sciences (SBMS) (2011.1-2016.10) and the vice-dean of the College of Life Sciences (2004.4-2011.7), Wuhan University. He also served as the director of the Modern Virology Research Center and the Deputy Director of the National Key Laboratory of Virology at Wuhan University for a long period. Since August 2016, he served as the dean of the School of Medicine (Shenzhen), Sun Yat-sen University, China.
Dr. Guo focuses his work on molecular mechanisms of the infection and pathogenesis of RNA viruses, in particular, on the RNA genome replication and immune escape of coronaviruses. He has uncovered novel mechanisms of RNA modification and established high throughput platform for screening inhibitors targeting coronavirus methyltransferases. He discovered that the well-known tumor suppressor PTEN also plays a pivotal role in antiviral innate immunity. His group also adopts gene editing technologies to genetically modify or disrupt the HIV receptors and provirus of T cells and hematopoietic stem cells of the patients, aiming at functional cure of HIV/AIDS by genetic therapy. He published his work in Nature Immunology, PNAS, Hepatology, PLoS Pathogens, Journal of Immunology, Journal of Virology, etc. He has obtained several prestigious research awards and fundings. He was selected as National Distinguished Young Scholar by National Natural Science Foundation of China (NSFC) in 2009 and acts as the chief scientist of the National Basic Research Program (“973” project) in cellular antiviral innate immunity. He is also a scholar of National “WanRen Talents Program” for Sci & Tech Innovation.
He also acts as a member of several national committees of experts for counseling and evaluations, including expert panel of grant evaluation of China National Natural Science Foundation and CNAS Expert Committee for Laboratory Biosafety. Now he serves as the president of Virology Division of Chinese Society for Microbiology (equivalent to Chinese Society for Virology), and a managing member of the Medical Virology Division of Chinese Society for Medicine. He also serves as members of several editorial boards, such as Virology, Medical Microbiology and Immunity, Journal of Biosafety & Biosecurity, and Virologica Sinica.